Abbott Laboratories (ABT) closed at $109.93 on November 6, 2026, down 3.2% from the previous close, on volume of 6,297,145 shares (30-day average 9,345,245).
Data as of November 6, 2026.
6-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 19, 2026 | Risk Reversal | 21-Jan-2890 P : 130 C +285,000 Stock | 10,000 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
BofA adds TSLA, AVGO, IBM, others to its Global Defenders list
Seeking Alpha News (Thu, 5-Nov 10:17 AM ET)
PRNewswire (Mon, 2-Nov 9:00 AM ET)
PRNewswire (Sun, 1-Nov 3:45 PM ET)
PRNewswire (Thu, 29-Oct 9:01 AM ET)
PRNewswire (Mon, 26-Oct 9:01 AM ET)
PRNewswire (Fri, 23-Oct 9:16 AM ET)
Market Chameleon (Wed, 21-Oct 7:49 AM ET)
Market Chameleon (Wed, 21-Oct 3:52 AM ET)
Abbott Reports Third-Quarter 2026 Results and Reaffirms Full-Year EPS Guidance
PRNewswire (Wed, 21-Oct 7:30 AM ET)
PRNewswire (Wed, 21-Oct 7:25 AM ET)
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Abbott Laboratories trades on the NYSE stock market under the symbol ABT.
As of November 6, 2026, ABT stock price declined to $109.93 with 6,297,145 million shares trading.
ABT has a beta of -0.47, meaning it tends to be less sensitive to market movements. ABT has a correlation of 0.05 to the broad based SPY ETF.
ABT has a market cap of $190.22 billion. This is considered a Large Cap stock.
Last quarter Abbott Laboratories reported $13 billion in Revenue and $1.42 earnings per share. This beat revenue expectation by $27 million and met earnings estimates .
In the last 3 years, ABT traded as high as $141.23 and as low as $81.97.
The top ETF exchange traded funds that ABT belongs to (by Net Assets): VTI, SCHD, VOO, IVV, SPY.
ABT has underperformed the market in the last year with a return of -10.0%, while SPY returned +10.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ABT shares. However, ABT has outperformed the market in the last 3 month and 2 week periods, returning +2.4% and +6.0%, while SPY returned -4.1% and -3.2%, respectively. This indicates ABT has been having a stronger performance recently.
ABT support price is $111.30 and resistance is $115.90 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ABT shares will trade within this expected range on the day.
